To report 24-month vision and fluorescein angiographic outcomes from trials evaluating photodynamic therapy with verteporfin (Visudyne; CIBA Vision Corp, Duluth, Ga) in patients with subfoveal choroidal neovascularization (CNV) caused by age-related macular degeneration (AMD).
Title
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP report 2
Published in
Archives of ophthalmology
Volume
119
Issue
2
Pages
198-207
Date
2001
Publisher
American Medical Association
ISSN
0003-9950
Record creation date
2011-02-16